Atlas Trials

Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma

Clinical trial NCT01339039 · TERMINATED

Trial details

NCT number
NCT01339039
Sponsor
Patrick Y. Wen, MD
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
High Grade Glioma: Glioblastoma (GBM)High Grade Glioma: GliosarcomaAnaplastic Astrocytoma (AA)Anaplastic Oligodendroglioma (AO)Mixed Anaplastic Oligoastrocytoma (AOA)
Start date
2011-12-01
Primary completion
2014-04-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.